Jan Deprest

72 timestamped statements across 3 collections — auto-found in recorded discussions, each timestamp jumps to the exact moment.

Fetal Surgery · guest expert

Featured diaries

Ep 3 · 11:19
Why do we insist so much on removing the balloon prior to birth? That is mainly because we have seen that both the survival as well as the early morbidity is better if the balloon is removed in utero at least 24 hours prior to birth.
Ep 10 · 11:19
Why do we insist so much on removing the balloon prior to birth? That is mainly because we have seen that both the survival as well as the early morbidity is better if the balloon is removed in utero at least 24 hours prior to birth.
quote · Fetal Surgery
Ep 4 · 11:19
Why do we insist so much on removing the balloon prior to birth? That is mainly because we have seen that both the survival as well as the early morbidity is better if the balloon is removed in utero at least 24 hours prior to birth.
Ep 3 · 8:07
We really won't like to have a longitudinal position of the baby preferentially because when it is in transverse, it's a very unstable lay and the fetus will be difficult to access.
Ep 10 · 8:07
We really won't like to have a longitudinal position of the baby preferentially because when it is in transverse, it's a very unstable lay and the fetus will be difficult to access.
quote · Fetal Surgery
Ep 4 · 8:07
We really won't like to have a longitudinal position of the baby preferentially because when it is in transverse, it's a very unstable lay and the fetus will be difficult to access.

Nothing matches these filters — clear the search or widen the filters.

Fetoscopic endoluminal tracheal occlusion and twin-twin transfusion: Fetal...

Ep 3 · 0:27
quote I would like to share an experience we had in Europe here with this antenatal intervention for diaphragmatic cornea.
Ep 3 · 0:45
epidemiological Congenital diaphragmatic hernia occurs in 10-20% of monochorionic twin pregnancies and is responsible for large amounts of perinatal mortality and morbidity, with 80-100% mortality if untreated in the past.
Ep 3 · 1:20
clinical Patient selection for FETO is based on lung-to-head ratio (LHR) corrected for gestational age (observed/expected) and presence of liver herniation, with severe hypoplasia defined as maximum 20% survival, moderate 50%, and mild 85% survival.
Ep 3 · 2:28
quote The question for you basically is whether this is still actual.
Ep 3 · 2:36
host_summary External validation from Children's Hospital Philadelphia (2006-2010 cohort) and Toronto confirmed that outcomes remain dependent on lung-to-head ratio and these selection criteria are still valid.
Ep 3 · 3:19
clinical The FETO procedure is done at 26-28 weeks (now 29 weeks in updated protocol) under local anesthesia with fetal analgesia and immobilization, lasting 6-10 minutes on average when fetal position is favorable.
Ep 3 · 4:10
quote It is a very reasonable procedure.
Ep 3 · 8:07
quote We really won't like to have a longitudinal position of the baby preferentially because when it is in transverse, it's a very unstable lay and the fetus will be difficult to access.
Ep 3 · 8:32
clinical The median gestational age at birth after FETO was 35 weeks, similar to open fetal surgery, with 20-22% experiencing ruptured membranes by 34 weeks.
Ep 3 · 11:19
clinical Balloon removal in utero at least 24 hours prior to birth is associated with better survival and early morbidity compared to removal at delivery.
Ep 3 · 11:19
quote Why do we insist so much on removing the balloon prior to birth? That is mainly because we have seen that both the survival as well as the early morbidity is better if the balloon is removed in utero at least 24 hours prior to birth.
Ep 3 · 12:31
quote In very rare cases you can pick it up after birth either by puncture percutaneously or by tracheoscopy, but that's really not the recommended way to do.
Ep 3 · 12:42
clinical FETO increased survival from around 0% to 20% in the smallest lung group and by 30-35% on average in the severe hypoplasia group compared to historical controls.
Ep 3 · 13:44
clinical Independent predictors of survival after FETO are initial lung size prior to operation, gestational age at delivery, and ability to remove balloon in utero at least 24 hours before birth.
Ep 3 · 14:37
clinical Even with delivery prior to 32 weeks after FETO, survival rate is as high as predicted at term without fetal therapy; for delivery at 32 weeks or later, survival is 60%, which doesn't increase beyond 34 weeks.
Ep 3 · 14:53
quote In a very sarcastic way one can say that even if this complication occurs, we don't kill babies by doing an in utero intervention.
Ep 3 · 15:40
quote There is no reason at this moment to think that we have substituted mortality by morbidity.
Ep 3 · 15:50
clinical There is an apparent decrease in bronchopulmonary dysplasia after FETO, with no evidence of substituting mortality by morbidity based on oxygen need, ventilator days, time to full enteral feeding, and NICU days.
Ep 3 · 16:41
clinical The TOTAL trial in Europe compares tracheal occlusion at 27-29 weeks to expectant management, with survival as primary outcome in severe cases and survival without BPD in moderate cases.
Ep 3 · 19:45
guideline Centers offering FETO must have an active fetoscopy program (minimum 36 interventions per year or 3 per month), experience with 15 balloon occlusion cases (at least 5 done locally), and 24-hour balloon removal capability.
Ep 3 · 25:05
clinical In the moderate TTTS trial, 54 cases have been recruited beyond the first interim analysis, with all participating centers agreeing not to offer fetal therapy outside the trial.
Ep 3 · 25:44
opinion The severe FETO trial has been hampered by too long offering the procedure outside trial settings while trying to optimize technique, though the last 100 cases showed no improvement in outcomes.
Ep 3 · 25:44
quote We have too long gone on with offering this procedure, still trying to figure out small improvements, while actually we didn't learn from the last 100 cases.
Ep 3 · 26:45
quote There is nothing I can do about that.
Fetal Surgery 24 entries

Fetoscopic endoluminal tracheal occlusion and twin-twin transfusion: Fetal...

Ep 10 · 0:27
quote I would like to share an experience we had in Europe here with this antenatal intervention for diaphragmatic cornea.
Ep 10 · 0:45
epidemiological Congenital diaphragmatic hernia occurs in 10-20% of monochorionic twin pregnancies and is responsible for large amounts of perinatal mortality and morbidity, with 80-100% mortality if untreated in the past.
Ep 10 · 1:20
clinical Patient selection for FETO is based on lung-to-head ratio (LHR) corrected for gestational age (observed/expected) and presence of liver herniation, with severe hypoplasia defined as maximum 20% survival, moderate 50%, and mild 85% survival.
Ep 10 · 2:28
quote The question for you basically is whether this is still actual.
Ep 10 · 2:36
host_summary External validation from Children's Hospital Philadelphia (2006-2010 cohort) and Toronto confirmed that outcomes remain dependent on lung-to-head ratio and these selection criteria are still valid.
Ep 10 · 3:19
clinical The FETO procedure is done at 26-28 weeks (now 29 weeks in updated protocol) under local anesthesia with fetal analgesia and immobilization, lasting 6-10 minutes on average when fetal position is favorable.
Ep 10 · 4:10
quote It is a very reasonable procedure.
Ep 10 · 8:07
quote We really won't like to have a longitudinal position of the baby preferentially because when it is in transverse, it's a very unstable lay and the fetus will be difficult to access.
Ep 10 · 8:32
clinical The median gestational age at birth after FETO was 35 weeks, similar to open fetal surgery, with 20-22% experiencing ruptured membranes by 34 weeks.
Ep 10 · 11:19
clinical Balloon removal in utero at least 24 hours prior to birth is associated with better survival and early morbidity compared to removal at delivery.
Ep 10 · 11:19
quote Why do we insist so much on removing the balloon prior to birth? That is mainly because we have seen that both the survival as well as the early morbidity is better if the balloon is removed in utero at least 24 hours prior to birth.
Ep 10 · 12:31
quote In very rare cases you can pick it up after birth either by puncture percutaneously or by tracheoscopy, but that's really not the recommended way to do.
Ep 10 · 12:42
clinical FETO increased survival from around 0% to 20% in the smallest lung group and by 30-35% on average in the severe hypoplasia group compared to historical controls.
Ep 10 · 13:44
clinical Independent predictors of survival after FETO are initial lung size prior to operation, gestational age at delivery, and ability to remove balloon in utero at least 24 hours before birth.
Ep 10 · 14:37
clinical Even with delivery prior to 32 weeks after FETO, survival rate is as high as predicted at term without fetal therapy; for delivery at 32 weeks or later, survival is 60%, which doesn't increase beyond 34 weeks.
Ep 10 · 14:53
quote In a very sarcastic way one can say that even if this complication occurs, we don't kill babies by doing an in utero intervention.
Ep 10 · 15:40
quote There is no reason at this moment to think that we have substituted mortality by morbidity.
Ep 10 · 15:50
clinical There is an apparent decrease in bronchopulmonary dysplasia after FETO, with no evidence of substituting mortality by morbidity based on oxygen need, ventilator days, time to full enteral feeding, and NICU days.
Ep 10 · 16:41
clinical The TOTAL trial in Europe compares tracheal occlusion at 27-29 weeks to expectant management, with survival as primary outcome in severe cases and survival without BPD in moderate cases.
Ep 10 · 19:45
guideline Centers offering FETO must have an active fetoscopy program (minimum 36 interventions per year or 3 per month), experience with 15 balloon occlusion cases (at least 5 done locally), and 24-hour balloon removal capability.
Ep 10 · 25:05
clinical In the moderate TTTS trial, 54 cases have been recruited beyond the first interim analysis, with all participating centers agreeing not to offer fetal therapy outside the trial.
Ep 10 · 25:44
opinion The severe FETO trial has been hampered by too long offering the procedure outside trial settings while trying to optimize technique, though the last 100 cases showed no improvement in outcomes.
Ep 10 · 25:44
quote We have too long gone on with offering this procedure, still trying to figure out small improvements, while actually we didn't learn from the last 100 cases.
Ep 10 · 26:45
quote There is nothing I can do about that.

Fetoscopic endoluminal tracheal occlusion and twin-twin transfusion: Fetal...

Ep 4 · 0:27
quote I would like to share an experience we had in Europe here with this antenatal intervention for diaphragmatic cornea.
Ep 4 · 0:45
epidemiological Congenital diaphragmatic hernia occurs in 10-20% of monochorionic twin pregnancies and is responsible for large amounts of perinatal mortality and morbidity, with 80-100% mortality if untreated in the past.
Ep 4 · 1:20
clinical Patient selection for FETO is based on lung-to-head ratio (LHR) corrected for gestational age (observed/expected) and presence of liver herniation, with severe hypoplasia defined as maximum 20% survival, moderate 50%, and mild 85% survival.
Ep 4 · 2:28
quote The question for you basically is whether this is still actual.
Ep 4 · 2:36
host_summary External validation from Children's Hospital Philadelphia (2006-2010 cohort) and Toronto confirmed that outcomes remain dependent on lung-to-head ratio and these selection criteria are still valid.
Ep 4 · 3:19
clinical The FETO procedure is done at 26-28 weeks (now 29 weeks in updated protocol) under local anesthesia with fetal analgesia and immobilization, lasting 6-10 minutes on average when fetal position is favorable.
Ep 4 · 4:10
quote It is a very reasonable procedure.
Ep 4 · 8:07
quote We really won't like to have a longitudinal position of the baby preferentially because when it is in transverse, it's a very unstable lay and the fetus will be difficult to access.
Ep 4 · 8:32
clinical The median gestational age at birth after FETO was 35 weeks, similar to open fetal surgery, with 20-22% experiencing ruptured membranes by 34 weeks.
Ep 4 · 11:19
clinical Balloon removal in utero at least 24 hours prior to birth is associated with better survival and early morbidity compared to removal at delivery.
Ep 4 · 11:19
quote Why do we insist so much on removing the balloon prior to birth? That is mainly because we have seen that both the survival as well as the early morbidity is better if the balloon is removed in utero at least 24 hours prior to birth.
Ep 4 · 12:31
quote In very rare cases you can pick it up after birth either by puncture percutaneously or by tracheoscopy, but that's really not the recommended way to do.
Ep 4 · 12:42
clinical FETO increased survival from around 0% to 20% in the smallest lung group and by 30-35% on average in the severe hypoplasia group compared to historical controls.
Ep 4 · 13:44
clinical Independent predictors of survival after FETO are initial lung size prior to operation, gestational age at delivery, and ability to remove balloon in utero at least 24 hours before birth.
Ep 4 · 14:37
clinical Even with delivery prior to 32 weeks after FETO, survival rate is as high as predicted at term without fetal therapy; for delivery at 32 weeks or later, survival is 60%, which doesn't increase beyond 34 weeks.
Ep 4 · 14:53
quote In a very sarcastic way one can say that even if this complication occurs, we don't kill babies by doing an in utero intervention.
Ep 4 · 15:40
quote There is no reason at this moment to think that we have substituted mortality by morbidity.
Ep 4 · 15:50
clinical There is an apparent decrease in bronchopulmonary dysplasia after FETO, with no evidence of substituting mortality by morbidity based on oxygen need, ventilator days, time to full enteral feeding, and NICU days.
Ep 4 · 16:41
clinical The TOTAL trial in Europe compares tracheal occlusion at 27-29 weeks to expectant management, with survival as primary outcome in severe cases and survival without BPD in moderate cases.
Ep 4 · 19:45
guideline Centers offering FETO must have an active fetoscopy program (minimum 36 interventions per year or 3 per month), experience with 15 balloon occlusion cases (at least 5 done locally), and 24-hour balloon removal capability.
Ep 4 · 25:05
clinical In the moderate TTTS trial, 54 cases have been recruited beyond the first interim analysis, with all participating centers agreeing not to offer fetal therapy outside the trial.
Ep 4 · 25:44
opinion The severe FETO trial has been hampered by too long offering the procedure outside trial settings while trying to optimize technique, though the last 100 cases showed no improvement in outcomes.
Ep 4 · 25:44
quote We have too long gone on with offering this procedure, still trying to figure out small improvements, while actually we didn't learn from the last 100 cases.
Ep 4 · 26:45
quote There is nothing I can do about that.